Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.63% | 1.00% | 2.56% | 3.64% | 5.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.63% | 1.00% | 2.56% | 3.64% | 5.02% |
| Cost of Revenue | -4.05% | -6.54% | -9.29% | 1.06% | 6.76% |
| Gross Profit | 6.82% | 5.61% | 9.87% | 5.13% | 3.96% |
| SG&A Expenses | -4.06% | -5.66% | 7.42% | -0.45% | 0.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.69% | -5.97% | 0.51% | 0.16% | 3.98% |
| Operating Income | 77.56% | 129.47% | 87.07% | 38.00% | 19.23% |
| Income Before Tax | 201.85% | -37.92% | -445.55% | 307.31% | -47.56% |
| Income Tax Expenses | 454.93% | -32.91% | -66.43% | 278.56% | -224.22% |
| Earnings from Continuing Operations | 75.32% | -40.32% | 41.86% | 316.59% | -27.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.32% | -40.32% | 41.86% | 316.59% | -27.77% |
| EBIT | 77.56% | 129.47% | 87.07% | 38.00% | 19.23% |
| EBITDA | 31.93% | 40.52% | -5.22% | 21.41% | 5.41% |
| EPS Basic | 71.22% | -42.34% | 42.97% | 312.57% | -29.07% |
| Normalized Basic EPS | 194.75% | -40.03% | -438.87% | 303.49% | -53.98% |
| EPS Diluted | 66.96% | -42.35% | 42.97% | 309.68% | -28.70% |
| Normalized Diluted EPS | 190.08% | -40.12% | -438.87% | 302.27% | -53.68% |
| Average Basic Shares Outstanding | 2.39% | 3.51% | 1.93% | 1.90% | 1.83% |
| Average Diluted Shares Outstanding | 4.07% | 3.67% | 1.93% | 2.51% | 1.17% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.42% | 0.70% | -0.75% | 1.47% | 0.41% |